These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16982570)

  • 1. Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease.
    Prestia A; Rossi R; Geroldi C; Galluzzi S; Ettori M; Alaimo G; Frisoni GB
    Exp Aging Res; 2006; 32(4):395-410. PubMed ID: 16982570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease.
    Rami L; Bosch B; Sanchez-Valle R; Molinuevo JL
    Arch Gerontol Geriatr; 2010; 50(2):171-4. PubMed ID: 19375179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes.
    Xu G; Meyer JS; Thornby J; Chowdhury M; Quach M
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1027-33. PubMed ID: 12404652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spanish version of the Memory Impairment Screen (MIS): normative data and discriminant validity].
    Böhm P; Peña-Casanova J; Gramunt N; Manero RM; Terrón C; Quiñones-Ubeda S
    Neurologia; 2005 Oct; 20(8):402-11. PubMed ID: 16217689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Severe Cognitive Impairment Rating Scale--an instrument for the assessment of cognition in moderate to severe dementia patients.
    Choe JY; Youn JC; Park JH; Park IS; Jeong JW; Lee WH; Lee SB; Park YS; Jhoo JH; Lee DY; Kim KW
    Dement Geriatr Cogn Disord; 2008; 25(4):321-8. PubMed ID: 18319591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for mild cognitive impairment: usefulness of the 7-Minute Screen Test].
    Drake M; Butman J; Fontan L; Lorenzo J; Harris P; Allegri RF; Ollari JA
    Actas Esp Psiquiatr; 2003; 31(5):252-5. PubMed ID: 14557949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Alzheimer's disease: the 7 Minute Screen.
    Solomon PR; Pendlebury WW
    Fam Med; 1998 Apr; 30(4):265-71. PubMed ID: 9568495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
    Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin.
    Zhou A; Jia J
    J Int Neuropsychol Soc; 2009 Nov; 15(6):898-905. PubMed ID: 19891819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors.
    Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.